iScience (Nov 2022)

Endogenous metabolism in endothelial and immune cells generates most of the tissue vitamin B3 (nicotinamide)

  • Julianna D. Zeidler,
  • Claudia C.S. Chini,
  • Karina S. Kanamori,
  • Sonu Kashyap,
  • Jair M. Espindola-Netto,
  • Katie Thompson,
  • Gina Warner,
  • Fernanda S. Cabral,
  • Thais R. Peclat,
  • Lilian Sales Gomez,
  • Sierra A. Lopez,
  • Miles K. Wandersee,
  • Renee A. Schoon,
  • Kimberly Reid,
  • Keir Menzies,
  • Felipe Beckedorff,
  • Joel M. Reid,
  • Sebastian Brachs,
  • Ralph G. Meyer,
  • Mirella L. Meyer-Ficca,
  • Eduardo Nunes Chini

Journal volume & issue
Vol. 25, no. 11
p. 105431

Abstract

Read online

Summary: In mammals, nicotinamide (NAM) is the primary NAD precursor available in circulation, a signaling molecule, and a precursor for methyl-nicotinamide (M-NAM) synthesis. However, our knowledge about how the body regulates tissue NAM levels is still limited. Here we demonstrate that dietary vitamin B3 partially regulates plasma NAM and NAM-derived metabolites, but not their tissue levels. We found that NAD de novo synthesis from tryptophan contributes to plasma and tissue NAM, likely by providing substrates for NAD-degrading enzymes. We also demonstrate that tissue NAM is mainly generated by endogenous metabolism and that the NADase CD38 is the main enzyme that produces tissue NAM. Tissue-specific CD38-floxed mice revealed that CD38 activity on endothelial and immune cells is the major contributor to tissue steady-state levels of NAM in tissues like spleen and heart. Our findings uncover the presence of different pools of NAM in the body and a central role for CD38 in regulating tissue NAM levels.

Keywords